Study of the Effect of the Cognitive Orientation to Daily Occupational Performance (CO-OP) on Cognitive Impairment in Parkinson's Disease
Parkinson's Disease, Cognitive Impairment
About this trial
This is an interventional treatment trial for Parkinson's Disease focused on measuring Cognitive Orientation to daily Occupational Performance, CO-OP
Eligibility Criteria
Inclusion Criteria for Participants with Parkinson's disease:
- Clinical diagnosis of Idiopathic Parkinson's Disease
- Presence of a live-in caregiver or significant other who is willing to participate in the study
- Montreal Cognitive Assessment (MoCA) score above 16/30 and below 26/30
- Schwab and England Activities of Daily Living Scale scores between 60% and 90%
- Hoehn and Yahr Scale scores between Stage 1 and Stage 3
- Self-reported difficulty completing routine functional activities that may be related to new cognitive changes since PD diagnosis
Exclusion Criteria for Participants with Parkinson's disease:
- Clinical diagnosis of atypical parkinsonism
- Clinical diagnosis of young-onset Parkinson's disease
- Co-morbidities associated with cognitive impairment
- Poorly controlled depression
- Clinical diagnosis of dementia
- Residence outside boundaries of the city of Winnipeg, Manitoba, Canada
Inclusion Criteria for Caregiver Participants:
- Live in the same residence as participant with Parkinson's
- Be willing to participate
Exclusion Criteria for Caregiver Participants:
- Scores at or below 16/30 on Montreal Cognitive Assessment (MoCA)
Sites / Locations
- Deer Lodge Centre
Arms of the Study
Arm 1
Experimental
CO-OP treatment protocol
Participants with Parkinson's disease will be participating in up to 12 one-on-one treatment sessions with 2 sessions per week, for up to 6 weeks. Each session will last 45-60 minutes. During these treatment sessions, each participant will be taught a problem-solving strategy that teaches individuals to monitor and adjust their own actions. Participants will be guided by the principal investigator to select 5 individual treatment goals to work on during treatment. Sessions will continue until all 5 treatment goals have been met or until 12 sessions have been completed, whichever occurs earlier. Initially, each participant's respective primary caregiver will be required to attend treatment sessions, so that the caregiver may be familiar with the treatment strategy in order to coach the participant with Parkinson's disease when you he or she uses the strategy at home.